What the analyst said
Melius Research analyst Ben Reitzes reiterated a Hold rating on NVIDIA (NASDAQ: NVDA).
“We don’t think Nvidia benefits from raising guidance tomorrow given all the unknowns.”
“Buckle-up for what could be the most important conference call of our careers.”
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Track record
Firm track recordMelius Research: 70% of its 10 targets at least a year old were reached within 12 months; on NVIDIA, 1 of 3. Accuracy ranking →
Melius Research on NVIDIA
Melius Research price targets on NVIDIA
6 calls from November 20, 2025 to November 16, 2026. The target went from $320 to $185 (−42%). The rating moved from Buy to Hold.
$200$300$400$320$350$400$420This noteHoldNVDA $156.14
November 2025Today
Melius Research targetNVDA share price
- November 16, 2026 This noteRating only, no price targetHoldNo target
- November 12, 2026Downgraded to Hold, target cut from $420 (−56%)Hold$185
- August 27, 2026Target raised from $400 (+5%)Buy$420
- May 21, 2026Target raised from $350 (+14%)Buy$400
- January 5, 2026Target raised from $320 (+9%)Buy$350
- November 20, 2025Earliest call shownBuy$320





